Pu drug marketing channel innovation.docVIP

Pu drug marketing channel innovation What are generic drugs? This fact, the term endemic to China does not have a clear idea that generic drugs are often used in clinical practice has been widely used for many years, or conventional medicine. Generic drugs typically have some common features, such as low-tech market enterprises on production or sales, product entering the market easier and cheaper in clinical medicine has become a fixed habit. Thus, while generic drugs competition is fierce, but few companies targeted promotions, sales are usually allocated to rely on the traditional business model is basically a natural sell. At present our existing thousand kinds of drugs are mostly generic drugs, generic drugs account for drug consumption, the vast majority of consumers. Drug consumption structure in China there is a clear urban-rural differences and regional disparities, medication structural imbalance is the basis for the development of generic drugs exist. The basic medical insurance system for urban workers ‘low level, wide coverage’ principle, but also to generic drugs provides a larger space for development. Thus, for a very long period of time, the development potential of generic drugs remains high. Pu domestic drug sales of many enterprises still in the extensive management phase, the lack of deep-level mining, the lack of new sales concepts and methods of actively trying. In fact, if we rely solely on generic drugs from the commercial operation of the market allocation of shift refinement, generic drugs market can do it well. How, then, refinement of generic drugs to operate? ■ to find differences from the homogenization Generic drugs faced homogeneous market environment, the production of medicines and equipment in the S amp;amp; P, sale price and routine clinical application is difficult to find points of difference. However, this does not mean that different brands of generic drugs would be no difference, in fact, the difference not only exists,